about
Immunotherapy for tuberculosis: future prospectsPotential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosisTuberculosis and diabetes: current state and future perspectivesAddressing diabetes mellitus as part of the strategy for ending TB.Diabetes-related tuberculosis in the Middle East: an urgent need for regional research.Mitochondria in the regulation of innate and adaptive immunityAdjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate VaccinationGranulomas and Inflammation: Host-Directed Therapies for Tuberculosis.Immune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious DiseasesMetformin Induces Cell Cycle Arrest, Reduced Proliferation, Wound Healing Impairment In Vivo and Is Associated to Clinical Outcomes in Diabetic Foot Ulcer PatientsDefining a research agenda to address the converging epidemics of tuberculosis and diabetes. Part 2: Underlying biological mechanisms.Early interventions for diabetes related tuberculosis associate with hastened sputum microbiological clearance in Virginia, USA.Communicable and non-communicable diseases: connections, synergies and benefits of integrating care.Ohmyungsamycins promote antimicrobial responses through autophagy activation via AMP-activated protein kinase pathway.Applying Precision Medicine and Immunotherapy Advances from Oncology to Host-Directed Therapies for Infectious DiseasesHost sirtuin 1 regulates mycobacterial immunopathogenesis and represents a therapeutic target against tuberculosis.Advancing host-directed therapy for tuberculosis.Diabetes mellitus and tuberculosis: programmatic management issues.Glycemic Control and the Risk of Tuberculosis: A Cohort Study.Association between Use of Oral Anti-Diabetic Drugs and the Risk of Sepsis: A Nested Case-Control StudyToxoplasma gondii GRA7-Targeted ASC and PLD1 Promote Antibacterial Host Defense via PKCαTargeting Batf2 for infectious diseases and cancer.Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a reviewFine-tuning of macrophage activation using synthetic rocaglate derivatives.High Prevalence and Heterogeneity of Diabetes in Patients With TB in South India: A Report from the Effects of Diabetes on Tuberculosis Severity (EDOTS) StudyHost AMPK Is a Modulator of Plasmodium Liver InfectionStimulation through CD40 and TLR-4 Is an Effective Host Directed Therapy against Mycobacterium tuberculosis.Diabetes and Tuberculosis.Morphoproteomic-Guided Host-Directed Therapy for Tuberculosis.AMP-activated Protein Kinase As a Target For Pathogens: Friends Or Foes?Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus.Multi-target drugs to address multiple checkpoints in complex inflammatory pathologies: evolutionary cues for novel "first-in-class" anti-inflammatory drug candidates: a reviewer's perspective.The trials and tribulations of repurposing metformin and other generic drugs for tuberculosis.Metabolic crosstalk between host and pathogen: sensing, adapting and competing.Transient Hyperglycemia in Patients With Tuberculosis in Tanzania: Implications for Diabetes Screening Algorithms.AMPK in Pathogens.Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity.Energetic interventions for healthspan and resiliency with aging.Translational Research in the Nonhuman Primate Model of Tuberculosis.Potential effect of ezetimibe against Mycobacterium tuberculosis infection in type II diabetes.
P2860
Q26741261-B586F9E4-2F51-4CF2-AAD1-C779C6EABD10Q26746099-A8E697DC-A088-4531-A722-5559858987F4Q26751215-DD9B64EC-C9B9-470F-AF91-9CB237F25E40Q26765390-D9AB9694-B301-4FD8-9D6F-DCB9AFBD42C7Q26786671-8E555F92-710F-48E0-820B-5CC0C3E16AFEQ26992186-00F4F7F4-B6E3-4E36-B16E-C6D16C34F061Q28074536-1B18E325-BCBA-4F3D-9F0E-900952B91464Q28076037-C516FEF8-5524-4D35-84C0-2A6D2C01B517Q28081001-CE74D8BA-9E80-449F-A48C-9A75AA48A845Q28550674-62C45FFB-4891-4270-9F13-550407D34053Q30234697-A6A7A44C-43D3-4F79-A88F-FC53D9C5B8E9Q30274831-A6911FFE-7B13-4091-9E48-94CA64FEA464Q30387611-2CFF9102-A8AA-4F47-94A3-CD5BBE7971A7Q33794131-325FBDE0-5D46-4820-BC58-E7EADF26B982Q33849778-62E7216E-E8B7-4488-AD64-1C1921434E1DQ33894427-0EB830F9-236B-4D9D-A8BF-AA2E822E2723Q34466861-392ABFF5-A17F-49A4-91B9-84089FE51AC3Q35835878-67BEA17F-0792-4D8A-84AA-CED74E939CD1Q36098831-90F1BCC8-CCDA-43A6-95AD-0170E8A6B842Q36158762-00B886A5-FB1D-4A37-B9A1-FDEA539ABDEBQ36261479-A84E155A-D698-485E-9857-11BB7C320B4BQ36413539-D76E47E5-B467-47CC-8196-C9DE9D06D957Q36653997-550DD944-2024-4E83-A02F-BDF9665F096DQ36806462-EAD3E188-58EE-4227-835B-F4B83F8D298DQ37094652-E0964F59-FAEB-4B48-B259-641B5D8F0048Q37239234-EA813173-7530-422E-B523-97E7B54E3152Q37284865-5BEED758-7349-4644-A070-48B3C7493FD8Q37590128-1AA8A4DD-018D-43F6-9CAF-C08376A1F2BDQ37619959-0B1C1CB4-E5CB-472F-8AA0-297DEE3F9F11Q37747266-6E497B71-2D05-4215-824F-A6E632BFE0F6Q38363794-97C0FB8A-3852-49B3-8A69-DE1780DA5D7CQ38549528-C26E436F-DBA4-402E-A051-CBB4062C4145Q38738703-850EA290-0640-45CD-AEBE-9FCD059431BAQ38763262-0ECD6725-6563-49BA-AF9D-C3264CDBD6F9Q38913416-57E455E3-D554-482B-99ED-A89A3A016885Q38998422-A5DF6D00-14C0-4153-9D4C-B1E02CA1D9A9Q39170824-C586A40C-A211-47BA-8820-CDEFA0EA0D9CQ39291992-D053955E-5484-4FEA-9457-8C1A74EC0EDCQ40175400-5EDE8C4D-1119-4EBA-9F51-8352C5E4132EQ40438875-5593EC3F-FBD5-47CB-9F32-79F15E6AD760
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Metformin as adjunct antituberculosis therapy.
@en
type
label
Metformin as adjunct antituberculosis therapy.
@en
prefLabel
Metformin as adjunct antituberculosis therapy.
@en
P2093
P50
P1476
Metformin as adjunct antituberculosis therapy.
@en
P2093
Amit Singhal
Barry Kreiswirth
Cynthia Chee
Francesca Zolezzi
Gan Suay Hong
Jinmiao Chen
Liana Tsenova
Melvin Khee-Shing Leow
Natalia Kurepina
P304
P356
10.1126/SCITRANSLMED.3009885
P407
P577
2014-11-01T00:00:00Z